Send to

Choose Destination
Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):36-44. doi: 10.1038/nrgastro.2013.141. Epub 2013 Aug 6.

Advances in the treatment of coeliac disease: an immunopathogenic perspective.

Author information

Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital and School of Medicine, University of Tampere, FI-33014 Tampere, Finland.
Tampere Center for Child Health Research, University of Tampere and Tampere University Hospital, University of Tampere, FI-33014 Tampere, Finland.


Coeliac disease is a common and fairly well-characterized systemic disorder that mainly affects the small intestine, but also has extraintestinal manifestations. The environmental trigger (gluten derived from wheat, rye and barley), the genetic predisposition conferred by the HLA-DQ2 and HLA-DQ8 haplotypes and many steps in the disease pathogenesis are known. This knowledge has enabled researchers to suggest novel alternative treatments or adjunctive therapies to the gluten-free diet, which is currently the only available and effective treatment for the condition. This Review focuses on emerging and potential treatment strategies that are based on the current concept of the disease pathophysiology. The search for novel future treatment modes, including nonpharmacological and pharmacological approaches, is also outlined. The potential pitfalls associated with the various research avenues are also discussed.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center